Feb 2019 107

Delivery of the Report will take 2-3 working days once order is placed.


Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

Scope of the Report:
North America ranks the top in terms of global market size of Antibody Drug Conjugate, it consists of 59.12% of the international market in 2016. Europe comes the second, with 27.70% of the global market. Asia Pacific consists of 6.54%of the Antibody Drug Conjugate market in the same year.
Takeda ranks the first in terms of revenue share in Global market of Antibody Drug Conjugate, occupies 54.17% of market share in 2016; While, Roche, with a market share of 35.11%, comes the second; The other companies consist of approximately 10.72% of the global market in 2016.
The worldwide market for Antibody-drug Conjugates is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Antibody-drug Conjugates in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- ImmunoGen
- Seattle Genetics
- Roche
- Takeda

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Adcetris
- Kadcyla

Market Segment by Applications, can be divided into
- Breast Cancer
- Lymphoma

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody-drug Conjugates product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antibody-drug Conjugates, with price, sales, revenue and global market share of Antibody-drug Conjugates in 2017 and 2018.
Chapter 3, the Antibody-drug Conjugates competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody-drug Conjugates breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Antibody-drug Conjugates market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Antibody-drug Conjugates sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Related reports :

(Jul 19)

All types of eye allergies are associated with chronic symptoms such as ocular itching inflammation redness and watery eyes, which are persi...

(Jul 19)

Radiodermatitis is the integumentary system's response to exposure to ionizing radiation. Scope of the Report: The worldwide ...

(Jul 19)

Staphylococcal infections are usually caused by the organism Staphylococcus aureus. Scope of the Report: The worldwide market ...

(Jul 19)

Equine supplement products market is driven by rise in demand for herbal equine supplements, increase in incidence of equine diseases, and s...

(Jul 19)

As the global healthcare space is seeing a palpable shift toward a 'value-based care' model, postoperative pain management is gaining its ve...

(Jul 19)

Scope of the Report: The worldwide market for Anti-AIDs Drug is expected to grow at a CAGR of roughly xx% over the next five years, w...


Global Info Research

Share this report on:

Subscription Option

Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports


Avail 15% Discount, Use JULY15 Coupon Code

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy